Pet Health News Is Elanco Animal Health Elan The Best Pet Stock To Invest In According To Analysts
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Pet Health News Is Elanco Animal Health Elan The Best Pet Stock To Invest In According To Analysts is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Elanco (ELAN): Buy, Sell, or Hold Post Q2 Earnings?
The past six months have been a windfall for Elanco’s shareholders. The company’s stock price has jumped 127%, hitting $21.47 per share. This was partly due to its solid quarterly results, and the ... Read More
Hsbc Holdings PLC Has $248,000 Stake in Elanco Animal Health Incorporated $ELAN

Hsbc Holdings PLC decreased its stake in shares of Elanco Animal Health Incorporated (NYSE:ELAN – Free Report) by 78.8% in the 1st quarter, according to the company in its most recent filing with the ... Read More
Assessing Elanco Animal Health: Insights From 6 Financial Analysts

Ratings for Elanco Animal Health (NYSE:ELAN) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ... Read More
Elanco gets FDA nod to remove vaccine risk warning from Zenrelia label

Elanco Animal Health (NYSE:ELAN) on Tuesday reported key updates to the U.S. label for Zenrelia, after the FDA reviewed additional scientific data, sending shares up 1.1% in premarket trading. The ... Read More
Elanco upgraded at J.P. Morgan on product launch cycle

J.P. Morgan upgraded Elanco Animal Health (NYSE:ELAN) to Overweight from Neutral on Tuesday, arguing that the veterinary product maker is set to accelerate its revenue growth over the next few years ... Read More
Elanco Innovation Builds Momentum, Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) Reaches Blockbuster Status

Credelio Quattro marked $100 million in net sales making it Elanco’s fastest pet health blockbuster in history and one of the industry’s fastest ever, especially with a single geographic approval ... Read More
Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms

Elanco Animal Health said on Friday it had received an emergency use authorization from the U.S. Food and Drug Administration for its flea and tick drug to treat dogs infected with a flesh-eating ... Read More
Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs
EUA to Treat Dogs for NWS Issued Prior to Fly Being Detected in the U.S.; Action Prepares Veterinarians and Pet Owners with Treatment Options First FDA emergency use authorization (EUA) ever granted ... Read More
Elanco Animal Health Incorporated (ELAN) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus

